Skip to content

Pyxis Oncology, Inc.

PYXS

CIK 0001782223

← back to feed
Revenue (TTM)
$13.86M
−14.2% YoY Q1 May 2026
Net Income (TTM)
−$84.79M
−3.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.37
+3.0% YoY Q1 May 2026
Gross Margin
82.8%
Q1 May 2026
Operating Margin
-652.9%
Q1 May 2026
Net Margin
-611.8%
Q1 May 2026
Free Cash Flow (TTM)
−$101.04M
Q1 May 2026
Cash
$5.77M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
63.36M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings